PDGFRA and Kaposi's sarcoma: This KSHV in vivo lytic switch is thus responsible for the activation of many autocrine and paracrine oncogenic signaling cascades, including the recently reported ligand-mediated activation of PDGFRA signaling pathway that drives KS tumorigenesis [14].